WEST PHARMACEUTICAL SERVICES, INC. APIC, Share-based Payment Arrangement, Increase for Cost Recognition
WEST PHARMACEUTICAL SERVICES, INC. (WST) reported APIC, Share-based Payment Arrangement, Increase for Cost Recognition of $11.10 million for the 3-month period ending 2024-09-30, per its 10-Q filed 2024-10-24.
Financial Statements › Shareholders' Equity
us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue · last filed 2024-10-24
- WEST PHARMACEUTICAL SERVICES, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2024-09-30 was $11.10M, a 59.64% decline year-over-year.
- WEST PHARMACEUTICAL SERVICES, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2024-06-30 was $11.10M, a 38.33% decline year-over-year.
- WEST PHARMACEUTICAL SERVICES, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2024-03-31 was $14.40M, a 30.91% increase year-over-year.
- WEST PHARMACEUTICAL SERVICES, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2023-09-30 was $27.50M.
- WEST PHARMACEUTICAL SERVICES, INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2018 was $16.50M, a 17.86% increase from fiscal 2017.
- WEST PHARMACEUTICAL SERVICES, INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2017 was $14.00M, a 19.08% decline from fiscal 2016.
- WEST PHARMACEUTICAL SERVICES, INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2016 was $17.30M, a 35.21% decline from fiscal 2015.
- WEST PHARMACEUTICAL SERVICES, INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2015 was $26.70M, a 75.66% increase from fiscal 2014.
| Period end | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 9 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 12 month |
|---|---|---|---|---|
| 2024-09-30 | $11.10M 10-Q · filed 2024-10-24 | $22.20M derived: sum of 2 quarters · filed 2024-10-24 | $36.60M derived: sum of 3 quarters · filed 2024-10-24 | |
| 2024-06-30 | $11.10M 10-Q · filed 2024-10-24 | $25.50M derived: sum of 2 quarters · filed 2024-10-24 | ||
| 2024-03-31 | $14.40M 10-Q · filed 2024-10-24 | |||
| 2023-09-30 | $27.50M 10-Q · filed 2024-10-24 | $45.50M derived: sum of 2 quarters · filed 2024-10-24 | $56.50M derived: sum of 3 quarters · filed 2024-10-24 | |
| 2023-06-30 | $18.00M 10-Q · filed 2024-10-24 | $29.00M derived: sum of 2 quarters · filed 2024-10-24 | ||
| 2023-03-31 | $11.00M 10-Q · filed 2024-10-24 | |||
| 2018-12-31 | $1.10M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | $5.00M derived: sum of 2 quarters · filed 2019-02-28 | $12.10M derived: sum of 3 quarters · filed 2019-02-28 | $16.50M 10-K · filed 2019-02-28 |
| 2018-09-30 | $3.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-30 | $11.00M derived: sum of 2 quarters · filed 2018-10-30 | $15.40M 10-Q · filed 2018-10-30 | $17.60M derived: sum of 4 quarters · filed 2019-02-28 |
| 2018-06-30 | $7.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-31 | $11.50M 10-Q · filed 2018-07-31 | $13.70M derived: sum of 3 quarters · filed 2019-02-28 | $18.40M derived: sum of 4 quarters · filed 2019-02-28 |
| 2018-03-31 | $4.40M 10-Q · filed 2018-05-08 | $6.60M derived: sum of 2 quarters · filed 2019-02-28 | $11.30M derived: sum of 3 quarters · filed 2019-02-28 | $11.60M derived: sum of 4 quarters · filed 2019-02-28 |
| 2017-12-31 | $2.20M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | $6.90M derived: sum of 2 quarters · filed 2019-02-28 | $7.20M derived: sum of 3 quarters · filed 2019-02-28 | $14.00M 10-K · filed 2019-02-28 |
| 2017-09-30 | $4.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-31 | $5.00M derived: sum of 2 quarters · filed 2017-10-31 | $11.80M 10-Q · filed 2017-10-31 | $16.10M derived: sum of 4 quarters · filed 2019-02-28 |
| 2017-06-30 | $300.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-01 | $7.10M 10-Q · filed 2017-08-01 | $11.40M derived: sum of 3 quarters · filed 2019-02-28 | $15.40M derived: sum of 4 quarters · filed 2019-02-28 |
| 2017-03-31 | $6.80M 10-Q · filed 2017-05-05 | $11.10M derived: sum of 2 quarters · filed 2019-02-28 | $15.10M derived: sum of 3 quarters · filed 2019-02-28 | $19.10M derived: sum of 4 quarters · filed 2019-02-28 |
| 2016-12-31 | $4.30M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | $8.30M derived: sum of 2 quarters · filed 2019-02-28 | $12.30M derived: sum of 3 quarters · filed 2019-02-28 | $17.30M 10-K · filed 2019-02-28 |
| 2016-09-30 | $4.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-31 | $8.00M derived: sum of 2 quarters · filed 2016-10-31 | $13.00M 10-Q · filed 2016-10-31 | $16.20M derived: sum of 4 quarters · filed 2018-02-26 |
| 2016-06-30 | $4.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-01 | $9.00M 10-Q · filed 2016-08-01 | $12.20M derived: sum of 3 quarters · filed 2018-02-26 | $16.30M derived: sum of 4 quarters · filed 2018-02-26 |
| 2016-03-31 | $5.00M 10-Q · filed 2016-05-06 | $8.20M derived: sum of 2 quarters · filed 2018-02-26 | $12.30M derived: sum of 3 quarters · filed 2018-02-26 | $27.60M derived: sum of 4 quarters · filed 2018-02-26 |
| 2015-12-31 | $3.20M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-26 | $7.30M derived: sum of 2 quarters · filed 2018-02-26 | $22.60M derived: sum of 3 quarters · filed 2018-02-26 | $26.70M 10-K · filed 2018-02-26 |
| 2015-09-30 | $4.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-02 | $19.40M derived: sum of 2 quarters · filed 2015-11-02 | $23.50M 10-Q · filed 2015-11-02 | $27.30M derived: sum of 4 quarters · filed 2017-02-28 |
| 2015-06-30 | $15.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-03 | $19.40M 10-Q · filed 2015-08-03 | $23.20M derived: sum of 3 quarters · filed 2017-02-28 | $26.00M derived: sum of 4 quarters · filed 2017-02-28 |
| 2015-03-31 | $4.10M 10-Q · filed 2015-05-06 | $7.90M derived: sum of 2 quarters · filed 2017-02-28 | $10.70M derived: sum of 3 quarters · filed 2017-02-28 | $15.00M derived: sum of 4 quarters · filed 2017-02-28 |
| 2014-12-31 | $3.80M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | $6.60M derived: sum of 2 quarters · filed 2017-02-28 | $10.90M derived: sum of 3 quarters · filed 2017-02-28 | $15.20M 10-K · filed 2017-02-28 |
| 2014-09-30 | $2.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-03 | $7.10M derived: sum of 2 quarters · filed 2014-11-03 | $11.40M 10-Q · filed 2014-11-03 | $14.90M derived: sum of 4 quarters · filed 2016-02-26 |
| 2014-06-30 | $4.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-01 | $8.60M 10-Q · filed 2014-08-01 | $12.10M derived: sum of 3 quarters · filed 2016-02-26 | $17.90M derived: sum of 4 quarters · filed 2016-02-26 |
| 2014-03-31 | $4.30M 10-Q · filed 2014-05-08 | $7.80M derived: sum of 2 quarters · filed 2016-02-26 | $13.60M derived: sum of 3 quarters · filed 2016-02-26 | $16.90M derived: sum of 4 quarters · filed 2016-02-26 |
| 2013-12-31 | $3.50M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-26 | $9.30M derived: sum of 2 quarters · filed 2016-02-26 | $12.60M derived: sum of 3 quarters · filed 2016-02-26 | $15.30M 10-K · filed 2016-02-26 |
| 2013-09-30 | $5.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-04 | $9.10M derived: sum of 2 quarters · filed 2013-11-04 | $11.80M 10-Q · filed 2013-11-04 | $14.60M derived: sum of 4 quarters · filed 2015-02-25 |
| 2013-06-30 | $3.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-05 | $6.00M 10-Q · filed 2013-08-05 | $8.80M derived: sum of 3 quarters · filed 2015-02-25 | $12.10M derived: sum of 4 quarters · filed 2015-02-25 |
| 2013-03-31 | $2.70M 10-Q · filed 2013-05-06 | $5.50M derived: sum of 2 quarters · filed 2015-02-25 | $8.80M derived: sum of 3 quarters · filed 2015-02-25 | $11.40M derived: sum of 4 quarters · filed 2015-02-25 |
| 2012-12-31 | $2.80M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-25 | $6.10M derived: sum of 2 quarters · filed 2015-02-25 | $8.70M derived: sum of 3 quarters · filed 2015-02-25 | $10.90M 10-K · filed 2015-02-25 |
| 2012-09-30 | $3.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-05 | $5.90M derived: sum of 2 quarters · filed 2012-11-05 | $8.10M 10-Q · filed 2012-11-05 | $9.90M derived: sum of 4 quarters · filed 2014-02-27 |
| 2012-06-30 | $2.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-06 | $4.80M 10-Q · filed 2012-08-06 | $6.60M derived: sum of 3 quarters · filed 2014-02-27 | $8.00M derived: sum of 4 quarters · filed 2014-02-27 |
| 2012-03-31 | $2.20M 10-Q · filed 2012-05-04 | $4.00M derived: sum of 2 quarters · filed 2014-02-27 | $5.40M derived: sum of 3 quarters · filed 2014-02-27 | $8.60M derived: sum of 4 quarters · filed 2014-02-27 |
| 2011-12-31 | $1.80M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-27 | $3.20M derived: sum of 2 quarters · filed 2014-02-27 | $6.40M derived: sum of 3 quarters · filed 2014-02-27 | $8.60M 10-K · filed 2014-02-27 |
| 2011-09-30 | $1.40M derived: 10-Q 9 month − 10-Q/A 6 month · filed 2011-11-07 | $4.60M derived: sum of 2 quarters · filed 2011-11-07 | $6.80M 10-Q · filed 2011-11-07 | $8.60M derived: sum of 4 quarters · filed 2013-02-27 |
| 2011-06-30 | $3.20M derived: 10-Q/A 6 month − 10-Q 3 month · filed 2011-08-08 | $5.40M 10-Q/A · filed 2011-08-08 | $7.20M derived: sum of 3 quarters · filed 2013-02-27 | $5.30M derived: sum of 4 quarters · filed 2013-02-27 |
| 2011-03-31 | $2.20M 10-Q · filed 2011-05-05 | $4.00M derived: sum of 2 quarters · filed 2013-02-27 | $2.10M derived: sum of 3 quarters · filed 2013-02-27 | |
| 2010-12-31 | $1.80M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-27 | -$100.00K derived: sum of 2 quarters · filed 2013-02-27 | $6.70M 10-K · filed 2013-02-27 | |
| 2010-09-30 | -$1.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2010-11-05 | $4.90M 10-Q · filed 2010-11-05 | ||
| 2010-06-30 | $6.80M 10-Q · filed 2010-08-05 | |||
| 2009-12-31 | $5.50M 10-K/A · filed 2012-03-01 | |||
| 2008-12-31 | $5.20M 10-K · filed 2011-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |